Category: DentalSyndicate content

Dental

Biolase launches $12M private placement amid internal turmoil, shares soar

July 21, 2014 by Arezu Sarvestani

Wall Street rallies as dental laser maker Biolase raises $12 million through a private placement round, even as the company deals with an ongoing civil war involving ousted CEO Federico Pignatelli.

Biolase launches $12M private placement

California-based Biolase (NSDQ:BIOL) announced today that it secured $12 million in a private placement funding round, even as the company weathers the internal tumult following the ouster of former CEO Federico Pignatelli.

Align Tech declares a 'total win' as federal circuit reverses ITC ruling

July 21, 2014 by Arezu Sarvestani

A new Federal Circuit Court ruling means Align Technology can move forward with a patent infringement case against rival ClearCorrect.

Align Tech declares a 'total win' as federal circuit reverses ITC ruling

Dental devices maker Align Technology (NSDQ:ALGN) touted a Federal Circuit Court ruling issued this month, calling it a "total win for Align."

McKesson dodges Medicare fraud charges

July 11, 2014 by Arezu Sarvestani

A federal judge dismisses a whistleblower lawsuit accusing McKesson of encouraging Medicare fraud and getting rid of workers who opposed the scheme.

McKesson dodges Medicare fraud charges

San Francisco-based healthcare giant McKesson (NYSE:MCK) dodged a Medicare fraud lawsuit this week after a federal judge ruled that prospective whistleblower Leslie Ann Williams didn't have enough evidence to support her accusations.

Ex-Biolase CEO isn't giving up without a fight

June 27, 2014 by Arezu Sarvestani

Ousted Biolase CEO Federico Pignatelli launches an investigation into the device maker, saying he suspects "wrongdoing, mismanagement and corporate governance failures."

Ex-Biolase CEO isn't giving up without a fight

Shares of Biolase (NSDQ:BIOL) got a modest boost today, even as a company insider announced a far-reaching investigation into the company's management under the suspicion of wrongdoing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

CEO Pignatelli out after court-ordered shake-up at Biolase

June 17, 2014 by Brad Perriello

Biolase CEO Federico Pignatelli is out after a court-ordered shake-up at Biolase.

CEO Pignatelli out in court-ordered shakeup at Biolase

The boardroom and C-suite at Biolase (NSDQ:BIOL) got a shake-up this week following a Delaware Supreme Court decision in a lawsuit filed by Oracle Partners earlier this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biolase vows to take another run at Fotona

June 13, 2014 by Brad Perriello

Biolase vows to amend its complaint after a federal judge shoots down its false advertising and defamation claims against rival dental laser maker Fotona.

Biolase vows to take another run at Fotona

A federal judge this month dismissed a Biolase (NSDQ:BIOL) lawsuit alleging false advertising and defamation by dental laser rival Fotona, but left the door open for an amended complaint.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Activist investor Oracle revives proxy war at Biolase

May 19, 2014 by Arezu Sarvestani

Oracle Partners issues a public statement to announce its "disappointment" over Biolase's Q1 results, which Biolase chairman & CEO Federico Pignatelli says is more evidence of the firm's attempts to take over the dental devices company.

Activist investor Oracle revives proxy war at Biolase

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp